Combined Therapeutics
PrivateLast Round
Early Funding
Mar 8, 2023
Total Funding Raised
$500,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Combined Therapeutics operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Grant round in September 2020.
Combined Therapeutics is a biotechnology company that develops mRNA-based vaccines and therapeutics for infectious diseases and oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Combined Therapeutics Comparables
Compare Combined Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Strand Therapeutics | 81% | |
| aceRNA Technologies Co., Ltd. | 81% | |
| Kernal Biologics | 81% |
For institutional investors. Book with your work email.
Combined Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 8, 2023 | ||||
| Grant | Sep 25, 2020 | ||||
| Seed | Dec 12, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 50% MoM.
- Jun 22, 2026
Monthly visitors grew 169% MoM, reaching 2.7K.
For institutional investors. Book with your work email.
Combined Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Combined Therapeutics's valuation, stock price, and market status.
Is Combined Therapeutics a public or private company?
Combined Therapeutics is a private company.
What is the current stock price of Combined Therapeutics?
Combined Therapeutics is a private company, so its shares have no public market price. Caplight tracks Combined Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Combined Therapeutics worth (valuation)?
Valuation information for Combined Therapeutics is not publicly available.
Can I buy Combined Therapeutics stock?
Combined Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Combined Therapeutics's last funding round?
Combined Therapeutics's most recent funding round was Early Funding on March 8, 2023.
Who are the main investors in Combined Therapeutics?
Investor information for Combined Therapeutics is not publicly disclosed.
Will Combined Therapeutics IPO soon?
No public IPO plans have been announced for Combined Therapeutics.
How can I track Combined Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Combined Therapeutics's shares on secondary markets.